Skip to main content
OpenTrials
Completed

NCT Number: NCT02938403

In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence

This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during the session using specialized counseling focused around their experience of using NRT, including how the use of NRT may help them quit smoking, side effects, and smoking cessation expectancies. In this study those in the In Vivo group will put the patch on during Session 1 and given nicotine gum in Session 2 and will discuss the experience of wearing the patch or chewing the gum while they are in session. The control group will not put on the patch or chew gum during the sessions but will be given standard counseling regarding quitting smoking.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Reduction or Abstinence Behavior Health Behavior Smoking Smoking Reduction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UAB Substance Abuse

Birmingham, Alabama, United States

About this study

Aim 1: Compare the efficacy of an In Vivo experiential intervention to a standard treatment control group for smoking cessation. The goal of this aim will be to compare the rates of point prevalence abstinence at the 6 month post-intervention follow-up. It is expected that smokers who receive the behavioral experience of the NRT In Vivo intervention will have higher rates of abstinence at the 6 month follow-up compared to the control group. Aim 2: Compare medication adherence between groups over the 12 week intervention. The goal of this aim is to determine the impact of the In Vivo behavioral experience intervention on promoting medication adherence to NRT. It is expected that individuals in the In Vivo NRT group will have better medication adherence relative to control participants. Exploratory: Examine moderators and mediators of the experimental intervention on smoking abstinence. The goal of this aim is to explore whether demographic and smoking characteristics (e.g., sex, race, nicotine dependence, motivational status, legal charges) moderate the effect of treatment on abstinence after 12 weeks of treatment and 6-month follow-up. In addition, we will look at changes in expectancies about NRT, medication adherence, and withdrawal symptoms to determine if these changes mediate the relationship between the experimental intervention and smoking abstinence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age,
  • Under criminal justice supervision and expecting to remain under supervision for 9 months,
  • Smoked at least 5 cigarettes per day for the last 12 months,
  • Expire carbon dioxide (CO)> 10 ppm.
  • Must be able to read and speak English.
  • Women of child-bearing potential must be using adequate birth control.

Exclusion criteria

  • Pregnant or breastfeeding women,
  • Non-English speaking,
  • Living in an restricted environment that does not allow smoking,
  • Known sensitivity to nicotine replacement or allergy to adhesive used in nicotine patches,
  • Cognitive impairment or major untreated mental illness that interferes with the informed consent process,
  • Within 6 months post-myocardial infarction or untreated severe angina,
  • Latex allergy,
  • Daily or exclusive use of other tobacco products (e.g. cigars, e-cigarettes).

Treatment and study plan

In vivo counseling

Behavioral

Participants in the intervention group will receive 4 in session nicotine replacement therapy and counseling focused on their experience of using NRT, including positive experiences, side effects and smoking cessation expectancies. They will also received nicotine replacement therapy (nicotine lozenge and patch) to use for smoking cessation.

Standard smoking cessation counseling

Behavioral

Participants will receive 4 sessions of standard behavioral counseling to address their smoking. In addition, participants will received nicotine replacement therapy (Nicotine lozenge and patch) to use for smoking cessation.

Primary outcomes

  1. Smoking abstinence

    Time frame: 6 months

    Smoking abstinence will be defined at 6 months as a CO< or equal to 3ppm and no smoking over the last 7 days

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2017
Primary completion
2021
Study completion
2022
First posted
Oct 19, 2016
Registry last updated
Apr 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.